These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15744280)

  • 1. Coupling and cross-presentation.
    Heath WR; Carbone FR
    Nature; 2005 Mar; 434(7029):27-8. PubMed ID: 15744280
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-presentation by intercellular peptide transfer through gap junctions.
    Neijssen J; Herberts C; Drijfhout JW; Reits E; Janssen L; Neefjes J
    Nature; 2005 Mar; 434(7029):83-8. PubMed ID: 15744304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen presentation. Naturally processed peptides.
    Elliott T; Townsend A; Cerundolo V
    Nature; 1990 Nov; 348(6298):195-7. PubMed ID: 2172837
    [No Abstract]   [Full Text] [Related]  

  • 4. On cross-priming of MHC class I-specific CTL: rule or exception?
    Zinkernagel RM
    Eur J Immunol; 2002 Sep; 32(9):2385-92. PubMed ID: 12207322
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunology. Accessory to murder.
    Schumacher TN
    Nature; 1999 Mar; 398(6722):26-7. PubMed ID: 10078525
    [No Abstract]   [Full Text] [Related]  

  • 6. Class I antigen presentation.
    Jelachich ML; Biddison WE
    Year Immunol; 1989; 4():41-58. PubMed ID: 2522701
    [No Abstract]   [Full Text] [Related]  

  • 7. Viral evasion of antigen presentation: not just for peptides anymore.
    Van Kaer L; Joyce S
    Nat Immunol; 2006 Aug; 7(8):795-7. PubMed ID: 16855602
    [No Abstract]   [Full Text] [Related]  

  • 8. Cross priming or direct priming: is that really the question?
    Norbury CC; Sigal LJ
    Curr Opin Immunol; 2003 Feb; 15(1):82-8. PubMed ID: 12495738
    [No Abstract]   [Full Text] [Related]  

  • 9. Making sense of mass destruction: quantitating MHC class I antigen presentation.
    Yewdell JW; Reits E; Neefjes J
    Nat Rev Immunol; 2003 Dec; 3(12):952-61. PubMed ID: 14647477
    [No Abstract]   [Full Text] [Related]  

  • 10. Subversion of the MHC class I antigen-presentation pathway by adenoviruses and herpes simplex viruses.
    Burgert HG
    Trends Microbiol; 1996 Mar; 4(3):107-12. PubMed ID: 8868089
    [No Abstract]   [Full Text] [Related]  

  • 11. Cross-presentation: underlying mechanisms and role in immune surveillance.
    Rock KL; Shen L
    Immunol Rev; 2005 Oct; 207():166-83. PubMed ID: 16181335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunology. Nothing 'gainst time's scythe can make defense..
    Ploegh HL
    Science; 2004 May; 304(5675):1262-3. PubMed ID: 15166355
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell biology. Peptides, scrambled and stitched.
    Shastri N
    Science; 2006 Sep; 313(5792):1398-9. PubMed ID: 16959995
    [No Abstract]   [Full Text] [Related]  

  • 14. Antigen presentation to cytotoxic T lymphocytes in vivo.
    Bevan MJ
    J Exp Med; 1995 Sep; 182(3):639-41. PubMed ID: 7650475
    [No Abstract]   [Full Text] [Related]  

  • 15. [HCV-specific cytotoxic T lymphocyte and its epitope].
    Morita H; Imawari M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):155-8. PubMed ID: 15359784
    [No Abstract]   [Full Text] [Related]  

  • 16. Mind the gap.
    Griffiths PD
    Rev Med Virol; 2005; 15(5):285-6. PubMed ID: 16134150
    [No Abstract]   [Full Text] [Related]  

  • 17. RPE cells resist bystander killing by CTLs, but are highly susceptible to antigen-dependent CTL killing.
    Gregerson DS; Lew KL; McPherson SW; Heuss ND; Ferrington DA
    Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5385-94. PubMed ID: 17122128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Viral strategies of interference with MHC functions].
    Ishido S; Goto E; Sato Y; Hotta H
    Tanpakushitsu Kakusan Koso; 2002 Dec; 47(16 Suppl):2145-51. PubMed ID: 12518428
    [No Abstract]   [Full Text] [Related]  

  • 19. Dendritic cells: open for presentation business.
    Saveanu L; van Endert P
    Nat Immunol; 2005 Jan; 6(1):7-8. PubMed ID: 15611772
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms of MHC class I-restricted antigen processing and cross-presentation.
    Cresswell P; Ackerman AL; Giodini A; Peaper DR; Wearsch PA
    Immunol Rev; 2005 Oct; 207():145-57. PubMed ID: 16181333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.